Based on the most effective inhibition of LSD1 activity, 4, 5-dimethoxycanthin-6-one was evaluated for its anticancer activity in vitro against T98G, U87, and U251 glioblastoma cells. The gene discussed is KDM1A; the disease is glioblastoma.